Integrated EZ Split Key Cup 10 AD DUA-1107-012-019 (25 Per Box)
$177.50 $175.00
- Description
- Reviews (0)
Description
Integrated EZ Split Key Cup 10 Panel + AD | DUA-1107-012-019
The Integrated EZ Split Key Cup 10 DUA-1107-012-019 with adulteration test for 10 different drugs of abuse plus 3 adulterants. Begin testing at your own convenience with the unique key activator. The Integrated EZ Split Key Cup requires minimal training and provides results in just 5 minutes. This product is 510(k) cleared to market.
Integrated EZ Split Key Cup 10 Panel Drug Test For:
COC, AMP, mAMP, OPI, THC, PCP, BAR, BZO, MDMA, and MTD
Built-In Adulteration Test For:
OX, PH, and SG
Features and Benefits
- Integrated EZ Split Key Cuptest for 10 drugs plus adulteration tests
- 510(k) cleared to market
- Begin testing at your convenience with unique key activator
- Reserved split specimen ideal for additional confirmation testing
- Fast test results in 5 minutes
For professional in vitro diagnostic use only.
Product Information
Integrated EZ Split Key Cup Brochure
Integrated EZ Split Key Cup Package Insert
Sold in boxes of 25 tests
Two-part drug test results forms included
Free Ground Shipping
For almost 20 years, we have been serving clients from all industries. We offer high quality products, competitive prices and superior customer service.
Be the first to review “Integrated EZ Split Key Cup 10 AD DUA-1107-012-019 (25 Per Box)” Cancel reply
You must be logged in to post a review.
Related Products
-
SaleAdd to cartQuick View
UScreen Ten 10 Panel Drug Test Kit +AD USSCUPA-10M
0 out of 5$148.75$124.95Add to cartQuick View -
Add to cartQuick View
Integrated EZ Split Key Cup 3 Panel Drug Test DOA-1237-019 (25 Per Box)
0 out of 5Add to cartQuick View -
SaleAdd to cartQuick View
Integrated EZ Split Key Cup 4 AD DUA-147-012-019 (25 Per Box)
0 out of 5$131.25$97.00Add to cartQuick View -
SaleAdd to cartQuick View
Integrated EZ Split Key Cup 5 AD DUA-157-036-019 (25 Per Box)
0 out of 5$148.75$118.75Add to cartQuick View
Reviews
There are no reviews yet.